Although CTCs have been mainly isolated from carcinomas through epithelial antigen-targeted antibodies (EpCAM), reports have demonstrated that EpCAM expression is not restricted to epithelial-derived tumors, but shared as well by CTCs isolated from patients with mesenchymal-derived cancers [7]. The gene discussed is EPCAM; the disease is cancer.